Pharma channel feed

Cell­tri­on looks to buy US fa­cil­i­ties to side­step po­ten­tial Trump tar­iffs 

3 months ago
Manufacturing

Ab­b­Vie rais­es Skyrizi and Rin­voq es­ti­mates, pre­dicts $31B in 2027 sales

3 months ago

Up­dat­ed: No­var­tis claims best earn­ings in years, val­i­dat­ing shift to pure-play strat­e­gy

3 months ago

Ver­tex's non-opi­oid pain drug is ap­proved by FDA, bring­ing first of new class to mar­ket

3 months ago
FDA+

Re­gen­eron wins ap­peals court or­ders back­ing halt on Eylea biosim­i­lars

3 months ago
Law

FDA ap­proves Ax­some's acute mi­graine treat­ment af­ter 2022 re­jec­tion

3 months ago
FDA+

Take­da scraps pro­grams as it rais­es full-year guid­ance 

3 months ago

Take­da CEO Christophe We­ber to re­tire in June 2026, Julie Kim to take over

3 months ago
People

Sanofi is in the mar­ket for M&A, thanks to ‘strong’ bal­ance sheet

3 months ago
Deals

Te­va CEO says Auste­do can grow 'way be­yond' im­pact of IRA

3 months ago

Trump ad­min­is­tra­tion makes first com­ments on how it will run IRA drug ne­go­ti­a­tions

3 months ago
FDA+

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

3 months ago
People
FDA+

Ahead of earn­ings, Lil­ly culls mid-stage drug for heart fail­ure and chron­ic kid­ney dis­ease

3 months ago
R&D

As­traZeneca and Dai­ichi Sanky­o's En­her­tu ap­proved in 'ul­tralow' HER2 pa­tients

3 months ago
FDA+

Ozem­pic la­bel ex­pand­ed to in­clude re­duced risk of wors­en­ing kid­ney dis­ease

3 months ago
FDA+

No­vo Nordisk asks Third Cir­cuit to ex­pe­dite IRA case as par­tic­i­pa­tion dead­line looms

3 months ago
Law

Sarep­ta shares two-year DMD study da­ta that could in­form Eu­ro­pean ap­proval de­ci­sion

3 months ago
R&D
FDA+

Phar­ma­cy mid­dle­men lose bid to toss new Hawaii com­plaint

3 months ago
Law

Pfiz­er inks $60M set­tle­ment to close Nurtec an­ti-kick­back suit

3 months ago
Law

Sage turns down Bio­gen's buy­out of­fer and will look at oth­er op­tions

3 months ago
Deals

Bris­tol My­ers shares IO com­bo da­ta in col­orec­tal can­cer; Pfiz­er still wait­ing on Braftovi reg­i­men sur­vival fig­ures

3 months ago
R&D

Trump blog: Fed­er­al agen­cies must give jobs back to fired pro­ba­tion­ary work­ers, judge rules

3 months ago
FDA+
In Focus

Ei­sai and Bio­gen win ap­proval for once-month­ly Leqem­bi main­te­nance dos­ing

3 months ago
FDA+

Mer­ck and Ei­sai re­veal late-stage fail for Keytru­da and Lenvi­ma in gas­troe­sophageal can­cer

3 months ago
R&D
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times